Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: Emergence of a novel OXA-182

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 4, 2010, Pages 432-438

  Kim, Chang Ki ^a,b   Lee, Yangsoon ^b   Lee, Hyukmin ^b,c   Woo, Gun Jo ^d   Song, Wonkeun ^e   Kim, Mi Na ^f   Lee, Wee Gyo ^g   Jeong, Seok Hoon ^b   Lee, Kyungwon ^b   Chong, Yunsop ^b  

^a Korean Institute of Tuberculosis   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

^d Korea University   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Ajou University School of Medicine   (South Korea)

Author keywords

Acinetobacter baumannii; Acinetobacter genomospecies; Korea; Metallo ? lactamase; OXA carbapenemase; OXA 182

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; SULBACTAM; TETRACYCLINE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTH KOREA; SPECIES IDENTIFICATION;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENETIC VARIATION; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREVALENCE; REPUBLIC OF KOREA; SPECIES SPECIFICITY;

EID: 78649265630     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.07.014     Document Type: Article

References (24)

1. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16s-23s rRNA gene spacer region. J. Clin. Microbiol. 2005, 43:1632-1639.
2. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement (M100-S19) 2009, CLSI, Wayne (PA).
3. Henwood C.J., Gatward T., Warner M., James D., Stockdale M.W., Spence R.P., Towner K.J., Livermore D.M., Woodford N. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (gar-936). J. Antimicrob. Chemother. 2002, 49:479-487.
4. Higgins P.G., Lehmann M., Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 2010, 305:35. (Epub).
5. Higgins P.G., Poirel L., Lehmann M., Nordmann P., Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D ?-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2009, 53:5035-5038.
6. Houang E.T., Chu Y.W., Chu K.Y., Ng K.C., Leung C.M., Cheng A.F. Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrob. Agents Chemother. 2003, 47:1472-1475.
7. Jeon B.C., Jeong S.H., Bae I.K., Kwon S.B., Lee K., Young D., Lee J.H., Song J.S., Lee S.H. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 ?-lactamase in Korea. J. Clin. Microbiol. 2005, 43:2241-2245.
8. Jeong S.H., Bae I.K., Park K.O., An Y.J., Sohn S.G., Jang S.J., Sung K.H., Yang K.S., Lee K., Young D., Lee S.H. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol. 2006, 44:423-431.
9. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., Chung D.R., Peck K.R., Song J.H. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 2007, 60:1163-1167.
10. Lee J.H., Choi C.H., Kang H.Y., Lee J.Y., Kim J., Lee Y.C., Seol S.Y., Cho D.T., Kim K.W., Song do Y., Lee J.C. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J. Antimicrob. Chemother. 2007, 59:633-639.
11. Lee K., Lee M., Lee J., Roh K.H., Kim S.J., Lee C.H., Kim J.J., Yong D., Jeong S.H., Chong Y. Antimicrobial resistance surveillance in Korea in 2007: increasing prevalence of vancomycin-resistant E. faecium, cefotaxime- and cefoxitin-resistant K. pneumoniae, and imipenem-resistant P. aeruginosa and Acinetobacter spp. P639, 19th ECCMID, Finland 2009, KONSAR group.
12. Lee K., Kim M.N., Choi T.Y., Cho S.E., Lee S., Whang D.H., Yong D., Chong Y., Woodford N., Livermore D.M. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int. J. Antimicrob. Agents 2009, 33:520-524.
13. Lee K., Lim C.H., Cho J.H., Lee W.G., Uh Y., Kim H.J., Yong D., Chong Y. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. Yonsei. Med. J. 2006, 47:634-645.
14. Lee K., Lim Y.S., Yong D., Yum J.H., Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-?-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 2003, 41:4623-4629.
15. Lee K., Lee W.G., Uh Y., Ha G.Y., Cho J., Chong Y. VIM- and IMP-type metallo-?-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Emerg. Infect. Dis. 2003, 9:868-871.
16. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 2005, 49:4485-4491.
17. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N. Engl. J. Med. 2008, 358:1271-1281.
18. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21:538-582.
19. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 2006, 12:826-836.
20. Sunenshine R.H., Wright M.O., Maragakis L.L., Harris A.D., Song X., Hebden J., Cosgrove S.E., Anderson A., Carnell J., Jernigan D.B., Kleinbaum D.G., Perl T.M., Standiford H.C., Srinivasan A. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 2007, 13:97-103.
21. Turton J.F., Gabriel S.N., Valderrey C., Kaufmann M.E., Pitt T.L. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 2007, 13:807-815.
22. OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 2006, 44:2974-2976.
23. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., Amyes S.G., Livermore D.M. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob Agents 2006, 27:351-353.
24. Yong D., Choi Y.S., Roh K.H., Kim C.K., Park Y.H., Yum J.H., Lee K., Chong Y. Increasing prevalence and diversity of metallo-?-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob. Agents Chemother. 2006, 50:1884-1886.